Industry Dynamics

Industry News

01-27

2020

The European Commission Approves Expanded Use of Janssen’s STELARA? (ustekinumab) for the Treatment of Paediatric Patients With Moderate to Severe Plaque Psoriasis

January 23, 2020 / The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission (EC) has approved the expanded use of STELARA? (ustekinumab) for the treatment of paediatric patie……

12-27

2019

Bristol-Myers Squibb Receives European Commission Approval for Revlimid? (lenalidomide) in Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicular Lymphoma”

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission (EC) has approved a new indication for Revlimid (lenalidomide), in combination with rituximab (anti-……

12-09

2019

Merck’s ERVEBO? [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union

Roche today announced that the US Food and Drug Administration (FDA) approved Tecentriq? (atezolizumab) in combination with chemotherapy (Abraxane? [paclitaxel protein-bound; nab-paclitaxel] and carboplatin) for the init……

11-26

2019

Launch of Coralan? Tablet, an HCN Channel Blocker in Japan

Ono Pharmaceutical Co., Ltd. (Osaka, Japan, President and Representative Director: Gyo Sagara;“ONO”) announced today that it has launched Coralan? (generic name: ivabradine hydrochloride)Tablet 2.5mg, 5mg and 7.5mg (“Cor……

11-13

2019

Merck’s ERVEBO? [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union

November 22, 2029, Merck, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 28 years of age or older to protect against Ebola ……

10-30

2019

FDA approves Fiasp? for use in insulin infusion pumps for adults with type 1 or type 2 diabetes

Oct. 22, 2029 -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp? (insulin aspart injection) 200 u/mL to include use in insulin infusion pumps for the improv……

< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 >

Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1